Literature DB >> 9384587

Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1.

A L Roy1, H Du, P D Gregor, C D Novina, E Martinez, R G Roeder.   

Abstract

The transcription factor TFII-I has been shown to bind independently to two distinct promoter elements, a pyrimidine-rich initiator (Inr) and a recognition site (E-box) for upstream stimulatory factor 1 (USF1), and to stimulate USF1 binding to both of these sites. Here we describe the isolation of a cDNA encoding TFII-I and demonstrate that the corresponding 120 kDa polypeptide, when expressed ectopically, is capable of binding to both Inr and E-box elements. The primary structure of TFII-I reveals novel features that include six directly repeated 90 residue motifs that each possess a potential helix-loop/span-helix homology. These unique structural features suggest that TFII-I may have the capacity for multiple protein-protein and, potentially, multiple protein-DNA interactions. Consistent with this hypothesis and with previous in vitro studies, we further demonstrate that ectopic TFII-I and USF1 can act synergistically, and in some cases independently, to activate transcription in vivo through both Inr and the E-box elements of the adenovirus major late promoter. We also describe domains of USF1 that are necessary for its independent and synergistic activation functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384587      PMCID: PMC1170311          DOI: 10.1093/emboj/16.23.7091

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

Review 1.  TAFs mediate transcriptional activation and promoter selectivity.

Authors:  C P Verrijzer; R Tjian
Journal:  Trends Biochem Sci       Date:  1996-09       Impact factor: 13.807

2.  The initiator element of the adenovirus major late promoter has an important role in transcription initiation in vivo.

Authors:  H Lu; M D Reach; E Minaya; C S Young
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 3.  The general transcription factors of RNA polymerase II.

Authors:  G Orphanides; T Lagrange; D Reinberg
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

Review 4.  Transcriptional activation by recruitment.

Authors:  M Ptashne; A Gann
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

Review 5.  Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes.

Authors:  S T Smale
Journal:  Biochim Biophys Acta       Date:  1997-03-20

Review 6.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

7.  Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations.

Authors:  R Lathe
Journal:  J Mol Biol       Date:  1985-05-05       Impact factor: 5.469

8.  Eukaryotic gene transcription with purified components.

Authors:  J D Dignam; P L Martin; B S Shastry; R G Roeder
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

9.  Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region.

Authors:  M Sawadogo; R G Roeder
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

10.  A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: identity to TFII-I.

Authors:  D A Grueneberg; R W Henry; A Brauer; C D Novina; V Cheriyath; A L Roy; M Gilman
Journal:  Genes Dev       Date:  1997-10-01       Impact factor: 11.361

View more
  67 in total

1.  Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms.

Authors:  G Gilinger; V Bellofatto
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.

Authors:  C M Mobley; L Sealy
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 3.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

4.  Discrete promoter elements affect specific properties of RNA polymerase II transcription complexes.

Authors:  J W Steinke; S J Kopytek; D O Peterson
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

5.  Molecular dissection of DNA sequences and factors involved in slow muscle-specific transcription.

Authors:  S Calvo; D Vullhorst; P Venepally; J Cheng; I Karavanova; A Buonanno
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Characterization of the human beta-globin downstream promoter region.

Authors:  Kelly M Leach; Karen F Vieira; Sung-Hae Lee Kang; Ara Aslanian; Martin Teichmann; Robert G Roeder; Jörg Bungert
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

7.  Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

Authors:  Yahao Bu; Lingqiu Gao; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

8.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxbeta.

Authors:  María Isabel Tussié-Luna; Dashzeveg Bayarsaihan; Edward Seto; Frank H Ruddle; Ananda L Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

9.  Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.

Authors:  Xiaodong Zhao; Tianyi Wang; Bo Liu; Zhenzhou Wu; Shuo Yu; Tao Wang
Journal:  Tumour Biol       Date:  2014-12-06

10.  Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.

Authors:  Timothy A Hinsley; Pamela Cunliffe; Hannah J Tipney; Andrew Brass; May Tassabehji
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.